{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:34:00Z","timestamp":1794411240804,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Optimal management of haemodynamically significant patent ductus arteriosus (HsPDA) in premature babies remains controversial. Our aim is to compare death and\/or adverse neurodevelopmental outcomes in extremely low birth weight (ELBW) infants with HsPDA who were managed with conservative [C], medical [M] and\/or surgical [S] treatment, with secondary aim to examine short-term morbidities among [S] and [C] groups. The study also compared outcomes in very low birth weight (VLBW) infants with HsPDA and non-HsPDA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective study of VLBW preterm infants born before 29\u2009weeks in Singapore from 2007 to 2016 was conducted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 474 VLBW infants were admitted in NUH from 2007 to 2016. Infants aged between 24\u2009+\u20090 and 28\u2009+\u20096\u2009weeks of gestation, weighing \u22641500\u2009g and diagnosed with patent ductus arteriosus (PDA) were included in the study, of which 172 infants (124 HsPDA and 48 non-HsPDA) were analyzed. Among infants with HsPDA, 17 infants were managed with [C], 83 with [M] and 24 with [S]. Mortality was not increased regardless of the presence of HsPDA or treatment received. Infants with non-HsPDA were less likely to have isolated speech delay (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), but not global developmental delay (GDD). No significant differences in neurodevelopmental outcomes such as hearing loss, cerebral palsy (CP) and speech delay were found. [M\u2009+\u2009S] infants were at a higher risk of developing chronic lung disease (CLD) (OR 6.83, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and short-term growth failure compared to [C] infants. They were significantly shorter and had a smaller head circumference at discharge (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). [M\u2009+\u2009S] infants also had elevated creatinine compared to those in group [C] (81.1\u2009\u00b1\u200924.1 vs 48.3\u2009\u00b1\u200911.8 umol\/L, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.000).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Compared to conservative management, infants requiring [M\u2009+\u2009S] treatment for HsPDA were more likely to have short-term complications such as CLD, elevated creatinine, and poorer growth. Despite a more turbulent postnatal course, death and\/or adverse neurodevelopmental outcomes were not worse in infants managed with [M\u2009+\u2009S].<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-021-02920-9","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T04:17:20Z","timestamp":1634617040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Retrospective comparison of death or neurodevelopmental outcomes in extremely low birth weight preterm infants following different management options of haemodynamically significant patent ductus arteriosus"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5466-8511","authenticated-orcid":false,"given":"Jania Jia-Ying","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-4902","authenticated-orcid":false,"given":"Krishnamoorthy","family":"Niduvaje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7503-4836","authenticated-orcid":false,"given":"Le ye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-5012","authenticated-orcid":false,"given":"Zubair","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"issue":"10","key":"2920_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1056\/NEJM200009073431009","volume":"343","author":"RI Clyman","year":"2000","unstructured":"Clyman RI. Ibuprofen and patent ductus arteriosus. N Engl J Med. 2000;343(10):728\u201330.","journal-title":"N Engl J Med"},{"issue":"3","key":"2920_CR2","first-page":"138","volume":"12","author":"JE Dice","year":"2007","unstructured":"Dice JE, Bhatia J. Patent ductus arteriosus: an overview. J Pediatr Pharmacol Ther. 2007;12(3):138\u201346.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2920_CR3","doi-asserted-by":"publisher","unstructured":"Semberova J, Sirc J, Miletin J, Kucera J, Berka I, Sebkova S, et al. Spontaneous closure of patent Ductus Arteriosus in infants \u22641500 g. Pediatrics. 2017;140(2):e20164258. https:\/\/doi.org\/10.1542\/peds.2016-4258.","DOI":"10.1542\/peds.2016-4258"},{"key":"2920_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fped.2017.00147","volume":"5","author":"R Arlettaz","year":"2017","unstructured":"Arlettaz R. Echocardiographic evaluation of patent Ductus Arteriosus in preterm infants. Front Pediatr. 2017;5:147.","journal-title":"Front Pediatr"},{"key":"2920_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fped.2020.00150","volume":"8","author":"MS Engeseth","year":"2020","unstructured":"Engeseth MS, Engan M, Clemm H, Volls\u00e6ter M, Nilsen RM, Markestad T, et al. Voice and exercise related respiratory symptoms in extremely preterm born children after neonatal patent Ductus Arteriosus. Front Pediatr. 2020;8:150.","journal-title":"Front Pediatr"},{"key":"2920_CR6","doi-asserted-by":"publisher","unstructured":"Benitz WE. Patent Ductus Arteriosus in preterm infants. Pediatrics. 2016;137(1):e20153730. https:\/\/doi.org\/10.1542\/peds.2015-3730.","DOI":"10.1542\/peds.2015-3730"},{"issue":"1","key":"2920_CR7","first-page":"21","volume":"14","author":"JL Shepherd","year":"2019","unstructured":"Shepherd JL, Noori S. What is a hemodynamically significant PDA in preterm infants? Congenit Heart Dis. 2019;14(1):21\u20136.","journal-title":"Congenit Heart Dis"},{"issue":"4","key":"2920_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/jp.2010.3","volume":"30","author":"WE Benitz","year":"2010","unstructured":"Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010;30(4):241\u201352.","journal-title":"J Perinatol"},{"issue":"4","key":"2920_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s13312-014-0403-2","volume":"51","author":"TK Ibrahim","year":"2014","unstructured":"Ibrahim TK, Haium AA, Chandran S, Rajadurai VS. Current controversies in the management of patent ductus arteriosus in preterm infants. Indian Pediatr. 2014;51(4):289\u201394.","journal-title":"Indian Pediatr"},{"issue":"7","key":"2920_CR10","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1542\/neo.19-7-e394","volume":"19","author":"M Gillam-Krakauer","year":"2018","unstructured":"Gillam-Krakauer M, Reese J. Diagnosis and Management of Patent Ductus Arteriosus. Neoreviews. 2018;19(7):e394\u2013402.","journal-title":"Neoreviews"},{"issue":"Suppl 1","key":"2920_CR11","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1038\/jp.2008.52","volume":"28","author":"KC Sekar","year":"2008","unstructured":"Sekar KC, Corff KE. Treatment of patent ductus arteriosus: indomethacin or ibuprofen? J Perinatol. 2008;28(Suppl 1):S60\u20132.","journal-title":"J Perinatol"},{"issue":"12","key":"2920_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/jp.2008.101","volume":"28","author":"LS Teixeira","year":"2008","unstructured":"Teixeira LS, Shivananda SP, Stephens D, Van Arsdell G, McNamara PJ. Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention. J Perinatol. 2008;28(12):803\u201310.","journal-title":"J Perinatol"},{"key":"2920_CR13","first-page":"74","volume":"27","author":"MS Engeseth","year":"2018","unstructured":"Engeseth MS, Olsen NR, Maeland S, Halvorsen T, Goode A, R\u00f8ksund OD. Left vocal cord paralysis after patent ductus arteriosus ligation: a systematic review. Paediatr Respir Rev. 2018;27:74\u201385.","journal-title":"Paediatr Respir Rev"},{"issue":"Suppl","key":"2920_CR14","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1038\/jp.2010.97","volume":"30","author":"S Noori","year":"2010","unstructured":"Noori S. Patent ductus arteriosus in the preterm infant: to treat or not to treat? J Perinatol. 2010;30(Suppl):S31\u20137.","journal-title":"J Perinatol"},{"issue":"2","key":"2920_CR15","volume":"2019","author":"S Mitra","year":"2019","unstructured":"Mitra S, Disher T. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants. Cochrane Database Syst Rev. 2019;2019(2):CD013278.","journal-title":"Cochrane Database Syst Rev"},{"key":"2920_CR16","doi-asserted-by":"crossref","unstructured":"Bhola K, Foster JP, Osborn DA. Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapy. Cochrane Database Syst Rev. 2015;(11):Cd009816.","DOI":"10.1002\/14651858.CD009816.pub2"},{"key":"2920_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2431-3-13","volume":"3","author":"TR Fenton","year":"2003","unstructured":"Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr. 2003;3:13.","journal-title":"BMC Pediatr"},{"issue":"6","key":"2920_CR18","first-page":"Sc08","volume":"9","author":"ZM Ezz-Eldin","year":"2015","unstructured":"Ezz-Eldin ZM, Hamid TA, Youssef MR, Nabil Hel D. Clinical risk index for babies (CRIB II) scoring system in prediction of mortality in premature babies. J Clin Diagn Res. 2015;9(6):Sc08\u201311.","journal-title":"J Clin Diagn Res"},{"key":"2920_CR19","first-page":"729","volume-title":"Intensive Care of the Fetus and Neonate","author":"JM Dabis","year":"2005","unstructured":"Dabis JM, Abman SH. Bronchopulmonary dysplasia. In: Spitzer AR, editor. Intensive Care of the Fetus and Neonate. 2nd ed: Mosby; 2005. p. 729\u201349.","edition":"2"},{"issue":"4","key":"2920_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","volume":"92","author":"LA Papile","year":"1978","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529\u201334.","journal-title":"J Pediatr"},{"issue":"1","key":"2920_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","volume":"187","author":"MJ Bell","year":"1978","unstructured":"Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1\u20137.","journal-title":"Ann Surg"},{"key":"2920_CR22","first-page":"233","volume":"102","author":"WV Good","year":"2004","unstructured":"Good WV. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233\u201348 discussion 248-250.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"2920_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/MOP.0b013e3283423e6b","volume":"23","author":"AH Jobe","year":"2011","unstructured":"Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr. 2011;23(2):167\u201372.","journal-title":"Curr Opin Pediatr"},{"key":"2920_CR24","doi-asserted-by":"publisher","unstructured":"Ngo S, Profit J, Gould JB, Lee HC. Trends in patent Ductus Arteriosus diagnosis and Management for Very low Birth Weight Infants. Pediatrics. 2017;139(4):e20162390. https:\/\/doi.org\/10.1542\/peds.2016-2390.","DOI":"10.1542\/peds.2016-2390"},{"issue":"11","key":"2920_CR25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1055\/s-0035-1548727","volume":"32","author":"T Isayama","year":"2015","unstructured":"Isayama T, Mirea L, Mori R, Kusuda S, Fujimura M, Lee SK, et al. Patent ductus arteriosus management and outcomes in Japan and Canada: comparison of proactive and selective approaches. Am J Perinatol. 2015;32(11):1087\u201394.","journal-title":"Am J Perinatol"},{"issue":"1","key":"2920_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13052-019-0706-y","volume":"45","author":"J Mydam","year":"2019","unstructured":"Mydam J, Rastogi A, Naheed ZJ. Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus. Ital J Pediatr. 2019;45(1):107.","journal-title":"Ital J Pediatr"},{"issue":"7","key":"2920_CR27","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00431-016-2731-9","volume":"175","author":"E Valerio","year":"2016","unstructured":"Valerio E, Valente MR, Salvadori S, Frigo AC, Baraldi E, Lago P. Intravenous paracetamol for PDA closure in the preterm: a single-center experience. Eur J Pediatr. 2016;175(7):953\u201366.","journal-title":"Eur J Pediatr"},{"issue":"11","key":"2920_CR28","first-page":"994","volume":"92","author":"CL Hermansen","year":"2015","unstructured":"Hermansen CL, Mahajan A. Newborn respiratory distress. Am Fam Physician. 2015;92(11):994\u20131002.","journal-title":"Am Fam Physician"},{"key":"2920_CR29","volume-title":"13th congress of the Asian Society for Pediatric Research: 2017","author":"S To","year":"2017","unstructured":"To S, Lee M, Siu KL. Predictors of failure of medical closure of patent ductus arteriosus in preterm infants. In: 13th congress of the Asian Society for Pediatric Research: 2017. Hong Kong: Hong Kong S.A.R; 2017."},{"issue":"6","key":"2920_CR30","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1542\/peds.2006-3124","volume":"119","author":"N Chorne","year":"2007","unstructured":"Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics. 2007;119(6):1165\u201374.","journal-title":"Pediatrics"},{"issue":"3","key":"2920_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jpeds.2006.11.039","volume":"150","author":"NS Kabra","year":"2007","unstructured":"Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in Preterms. J Pediatr. 2007;150(3):229\u201334 234.e221.","journal-title":"J Pediatr"},{"issue":"2","key":"2920_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1542\/peds.2007-2781","volume":"123","author":"JC Madan","year":"2009","unstructured":"Madan JC, Kendrick D, Hagadorn JI, Frantz ID 3rd. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics. 2009;123(2):674\u201381.","journal-title":"Pediatrics"},{"issue":"5","key":"2920_CR33","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jpeds.2015.06.054","volume":"167","author":"EM Janz-Robinson","year":"2015","unstructured":"Janz-Robinson EM, Badawi N, Walker K, Bajuk B, Abdel-Latif ME. Neurodevelopmental outcomes of premature infants treated for patent Ductus Arteriosus: a population-based cohort study. J Pediatr. 2015;167(5):1025\u20131032.e1023.","journal-title":"J Pediatr"},{"issue":"4","key":"2920_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0022-3476(78)80910-X","volume":"93","author":"RB Cotton","year":"1978","unstructured":"Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr. 1978;93(4):647\u201351.","journal-title":"J Pediatr"},{"issue":"6","key":"2920_CR35","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1542\/peds.104.6.1345","volume":"104","author":"DD Marshall","year":"1999","unstructured":"Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina neonatologists association. Pediatrics. 1999;104(6):1345\u201350.","journal-title":"Pediatrics"},{"key":"2920_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2431-12-10","volume":"12","author":"L Adrouche-Amrani","year":"2012","unstructured":"Adrouche-Amrani L, Green RS, Gluck KM, Lin J. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants. BMC Pediatr. 2012;12:10.","journal-title":"BMC Pediatr"},{"key":"2920_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jpeds.2018.09.012","volume":"205","author":"RI Clyman","year":"2019","unstructured":"Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, H\u00e5kansson S, et al. PDA-TOLERATE trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent Ductus Arteriosus at 1 week of age. J Pediatr. 2019;205:41\u201348.e46.","journal-title":"J Pediatr"},{"issue":"1","key":"2920_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12887-018-1215-7","volume":"18","author":"T Hundscheid","year":"2018","unstructured":"Hundscheid T, Onland W, van Overmeire B, Dijk P, van Kaam A, Dijkman KP, et al. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial). BMC Pediatr. 2018;18(1):262.","journal-title":"BMC Pediatr"},{"issue":"2","key":"2920_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jss.2014.02.003","volume":"190","author":"J Tashiro","year":"2014","unstructured":"Tashiro J, Wang B, Sola JE, Hogan AR, Neville HL, Perez EA. Patent ductus arteriosus ligation in premature infants in the United States. J Surg Res. 2014;190(2):613\u201322.","journal-title":"J Surg Res"},{"issue":"4","key":"2920_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/jp.2014.205","volume":"35","author":"P Agarwal","year":"2015","unstructured":"Agarwal P, Sriram B, Rajadurai VS. Neonatal outcome of extremely preterm Asian infants \u2a7d28 weeks over a decade in the new millennium. J Perinatol. 2015;35(4):297\u2013303.","journal-title":"J Perinatol"},{"issue":"7","key":"2920_CR41","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/sj.jp.7211754","volume":"27","author":"K Bohlin","year":"2007","unstructured":"Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol. 2007;27(7):422\u20137.","journal-title":"J Perinatol"},{"issue":"4","key":"2920_CR42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1542\/peds.2005-1706","volume":"117","author":"JS Mercer","year":"2006","unstructured":"Mercer JS, Vohr BR, McGrath MM, Padbury JF, Wallach M, Oh W. Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics. 2006;117(4):1235\u201342.","journal-title":"Pediatrics"},{"key":"2920_CR43","volume":"8","author":"H Rabe","year":"2012","unstructured":"Rabe H, Diaz-Rossello JL, Duley L, Dowswell T. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev. 2012;8:CD003248.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02920-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-02920-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02920-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T04:20:03Z","timestamp":1634617203000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-02920-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2920"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-02920-9","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"1 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was given by the National Health Group Domain Specific Ethics Review Board (NHG DSRB ref. 2020\/00001). The study is a retrospective review of existing data. Therefore, waiver of consent to participate was granted. Administrative permissions were given to access the raw data used in the study. This was in the ethics application for access to the raw data. The data used in the study was anonymised before its use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as the manuscript does not involve any identifiable personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"457"}}